New CFO at Entest BioMedical
This article was originally published in Scrip
Executive Summary
Entest BioMedical (US) has named Tammy Reynolds chief financial officer; she joins from Science Applications International. Entest is developing stem cell therapy treatments for chronic obstructive pulmonary disease (COPD), immunocancer therapies, testing procedures for diabetes, stem cell research applications for diabetes and other illnesses.